Click here for additional news beyond press releases.


Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000


December 17, 2002
Celera Genomics and Celera Diagnostics Discuss Strategy & Progress at Investor Meeting
December 17, 2002
Celera Genomics Appoints James Yee Head Of Development
December 11, 2002
FDA Grants Clearance For Celera Diagnostics ViroSeq HIV-1 Genotyping System
December 10, 2002
Celera Genomics And Celera Diagnostics To Webcast Investor Meeting
November 7, 2002
Celera Diagnostics To Investigate Breast Cancer With University Of California, San Francisco
October 24, 2002
Celera Genomics Reports First Quarter Fiscal 2003 Results
additional: Applera Corporation Teleconference, October 24, 2002 First Quarter Fiscal 2003 Earnings Call Script
October 15, 2002
Applied Biosystems Group and Celera Genomics Group First Quarter FY 2003 Financial Results and Conference Call Scheduled For October 24, 2002
October 8, 2002
Celera Genomics Purchases Rights to Preclinical Asthma Compounds from Bayer
October 7, 2002
Celera Diagnostics Announces Collaboration with Bristol-Myers Squibb to Study Cardiovascular Disease And Diabetes
October 2, 2002
Quest Diagnostics and Celera Diagnostics to Collaborate in Cardiovascular Disease and Diabetes
October 2, 2002
LabCorp and Celera Diagnostics to Collaborate in Alzheimer’s Disease and Breast and Prostate Cancer
September 26, 2002
Celera Genomics and Applied Biosystems Groups Announce Computational Infrastructure Upgrade
September 26, 2002
Celera Genomics and Applied Biosystems Select IBM Supercomputers and Services for Drug Discovery and Knowledge Businesses
September 26, 2002
Celera Genomics and Applied Biosystems Groups Select EMC for Automated Networked Storage
July 25, 2002
Celera Genomics Reports Fourth Quarter and Fiscal 2002 Results
additional: Applera Corporation Teleconference, July 25, 2002, Fourth Quarter Fiscal 2002 Earnings Call
July 11, 2002
Applied Biosystems Group and Celera Genomics Group Fourth Quarter and Year-End FY 2002 Financial Results and Conference Call Scheduled for July 25, 2002
July 8, 2002
Celera Genomics appoints Robert Booth Senior Vice President, Research & Development
June 24, 2002
Abbott Laboratories and Celera Diagnostics Form Alliance to Develop and Market Molecular Diagnostic Products
additional: Celera Diagnostics Teleconference; Celera Diagnostics-Abbott Laboratories Strategic Alliance
June 24, 2002
Abbott Laboratories and Celera Diagnostics Form Alliance to Develop and Market Molecular Diagnostic Products
June 11, 2002
Celera Genomics Implements Restructuring
May 30, 2002
Celera Genomics Publishes Analysis of Mouse Chromosome
April 25, 2002
Celera Reports Fiscal Third Quarter 2002 Results
additional: Applera Corporation Teleconference April 25, 2002 Third Quarter Fiscal 2002 Earnings Call
April 22, 2002
Applera Appoints Kathy Ordonez as President of Celera Genomics
April 22, 2002
Applera Announces New Applied Biosystems Knowledge Business and Marketing and Distribution Agreement for
April 19, 2002
Applera Management to Hold Conference Call to Discuss a New Business Initiative for Applied Biosystems and the Online Information Business of Celera Genomics
April 15, 2002
Applied Biosystems Group and Celera Genomics Group Third Quarter FY 2002 Financial Results and Conference Call Scheduled for Release April 25, 2002
March 4, 2002
Celera Sells Animal Genomics and Genotyping Business To Metamorphix, Inc.
February 14, 2002
Celera Compound Enters Development for Chagas Disease
February 12, 2002
Applied Biosystems and Vanderbilt University Form Collaboration to Research Advances in Proteomics and Small Molecule Analysis Using New Tissue Imaging and Profiling Application
February 11, 2002
Knut and Alice Wallenberg Foundation Subscribes To Celera Discovery System
February 11, 2002
Georgia Research Alliance Subscribes To Celera Discovery System
January 31, 2002
UK Medical Research Council and Celera Sign Agreement on Access to Genomic Database
January 23, 2002
Celera Reports Second Quarter Revenues of $35.0 Million
additional: Applera Corporation Teleconference January 24, 2002 Second Quarter Fiscal 2002 Earnings Call
January 23, 2002
Applied Biosystems Reports Second Quarter Fiscal 2002 Earnings Per Share of 24 Cents Excluding In-Process R&D Charge
January 22, 2002
J. Craig Venter Steps Down as President of Celera Genomics
January 18, 2002
Oxagen Subscribes To Celera's Genomic Databases
January 15, 2002
Applied Biosystems Group and Celera Genomics Group Second Quarter FY 2002 Financial Results Scheduled For Release January 23, 2002
January 10, 2002
Celera Announces Achievement of Research Milestone in Aventis Collaboration
January 7, 2002
David Block Appointed Executive Vice President of Celera and Chief Operating Officer of Celera's Therapeutics Business